<DOC>
	<DOCNO>NCT01091571</DOCNO>
	<brief_summary>During sepsis septic shock immune response overwhelm lead excessive tissue damage , organ failure death . Ideally , inflammatory response modulate lead adequate protection invade pathogen well limitation exuberant immune response . In last year adenosine propose central role modulation inflammation . In unfavorable condition hypoxia , ischemia inflammation adenosine quickly up-regulated ; concentration tenfold septic patient . Many animal study show adenosine able attenuate inflammatory response decrease mortality rate . Therefore , pharmacological elevation adenosine concentration potential target attenuate inflammation limit organ injury . Dipyridamole , adenosine re-uptake inhibitor able increase adenosine concentration limit ischemia-reperfusion injury . In order study effect dipyridamole inflammatory response aim use call human endotoxemia model . This model permit elucidation key player immune response gram negative stimulus vivo , therefore serve useful tool investigate potential novel therapeutic strategy standardize setting .</brief_summary>
	<brief_title>The Effects Oral Dipyridamole Treatment Innate Immune Response During Human Endotoxemia</brief_title>
	<detailed_description />
	<mesh_term>Endotoxemia</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<criteria>Age ≥ 18 ≤ 35 year Male Healthy Use medication . History allergic reaction dipyridamole Bleeding disorder . Smoking . Previous spontaneous vagal collapse . History , sign symptoms cardiovascular disease . Cardiac conduction abnormality ECG consist 2nd degree atrioventricular block complex bundle branch block . Hypertension ( define RR systolic &gt; 160 RR diastolic &gt; 90 ) . Hypotension ( define RR systolic &lt; 100 RR diastolic &lt; 50 ) . Renal impairment ( define plasma creatinin &gt; 120 μmol/l ) . Liver enzyme abnormality positive hepatitis serology . Positive HIV serology obvious disease associate immune deficiency . Febrile illness week LPS challenge . Participation another drug trial donation blood 3 month prior plan LPS challenge .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>Endotoxin</keyword>
	<keyword>Innate Immunity</keyword>
	<keyword>Dipyridamole</keyword>
</DOC>